Assembly Biosciences Inc reports results for the quarter ended in December - Earnings Summary

Assembly Biosciences

28/03/2024 22:04

* Assembly Biosciences Inc  ASMB.OQ  reported a quarterly
adjusted
loss of $2.15​​ per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of $-5.52.  The mean expectation of two analysts
for the quarter was for a loss of $2.88 per share. 
    * Reported revenue was zero​; analysts expected zero. 
    * Assembly Biosciences Inc's reported EPS for the quarter
was a
loss of $2.15​.
    * The company reported a quarterly loss of $11.49 million.
    * Assembly Biosciences Inc shares had risen by 36.0% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for Assembly
Biosciences Inc is $36.00 

This summary was machine generated from LSEG data March 28 at
10:04 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -2.88          -2.15          Beat
 Sep. 30 2023      -2.76          -3.24          Missed
 Jun. 30 2023      -3.48          -3.84          Missed
 Mar. 31 2023      -4.26          -4.44          Missed